secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001104659-24-032401
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics stockholders approve reverse stock split in range 30:1 to 75:1
--------------------------------------------------------------------------------

- Majority of voting power executed written consent on March 6, 2024, approving reverse stock split.
- Board authorized to determine exact ratio between 30-for-1 and 75-for-1.
- Holders of approximately 56% of voting power signed consent.
- Schedule 14C information statement to be filed with SEC and sent to stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924032401/0001104659-24-032401-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924032401/tm248309d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-032401

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer